Time frame : Baseline to post intervention

Slides:

Advertisements

Similar presentations

CHROMIUM SUPPLEMENTATION DECREASES INSULIN RESISTANCE AND TRUNK FAT Ellie Aghdassi, Ph.D., Irving E Salit, MD., Saira Mohammed, MSc.,Bianca M Arendt, Ph.D.,

Advertisements

Cholesterol Lipid Component of cell membrane Found in the diet – Eggs, dairy, liver High levels lead to development of CHD 2 types of cholesterol -carrying.

Slide Source: Lipid and Lipoprotein Parameters at Baseline and Drug Treatment: METEOR Trial Baseline, Mean (SD) Time-Weighted Average.

Effect of 21-day Holistic Therapy at “Our Native Village Eco Resorts” on Diabetes Mellitus as assessed by blood glucose levels and consumption of oral.

KINDS OF BLOOD TESTS. A-1-C HEMOGLOBIN ABO BLOOD TYPE.

Leptin Replacement Therapy Improves Insulin Resistance in Highly Active Antiretroviral Therapy (HAART) Induced Lipodystrophy and Metabolic Syndrome in.

© 2003, Wellsource Inc. Effect of Ketogenic Diet on Lipid Levels (shown is LDL-C) In this group of 141 children followed for 6 months, a ketogenic diet.

Diabetes Mellitus 101 for Cardiologists (and Alike): 2015

Assessing Nutritional Status Common Lab Values. Assessing Metabolism – The thyroid regulates metabolism – Thyroid studies include T3 T4 TSH.

L IPOPROTEINS. W HAT ARE LIPOPROTEINS ? Lipoproteins are molecules produced in the body and act as lipid transporters They consist of: Triglycerides Protein.

Patients’ Assignments,Values at Screening, and Baseline Efficacy and Safety Values - PartI JP Després, N Engl J Med 2005; 353:

METABOLISM of ADIPOSE TISSUE 2. LF UK Prof. Rudolf Poledne, PhD.

Date of download: 6/21/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Effectiveness of Pharmacist Interventions on.

Date of download: 7/5/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Effects of High vs Low Glycemic Index of Dietary Carbohydrate.

analysed to establish the distribution of GJD2 SNPs T2D patients

Optimal pharmacologic approach to patients with hypertriglyceridemia and low high- density lipoprotein-cholesterol: Randomized comparison of fenofibrate.

Independent variables (baseline) Loge (HOMA-IR) b P

Copyright © 2002 American Medical Association. All rights reserved.

© The Author(s) Published by Science and Education Publishing.

Go Woon Kim, Hee Kyung Jo, Sung Hyun Chung Journal of Ginseng Research

Insulin resistance in prepubertal children

x8 1.5hr weekly sessions with HT

Supplementary material

Potential effects of 10kg wt loss in Type 2 diabetes

Oxford Niacin Trial.

A Blend of Sesame and Rice Bran Oils Lowers Hyperglycemia and Improves the Lipids Sankar Devarajan, PhD, Biprabuddha Chatterjee, MSc, Hidenori Urata,

AGA KHAN UNIVERSITY HOSPITAL EID-UL-ADHA MUBARAK.

End point Muraglitazar 5 mg plus metformin (n=569)

Effects of High Density Lipoprotein Raising Therapies on Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus, with or without Renal Impairment:

Diabetes and Risk of CV Outcomes

Program Goals. Inhaled Insulin: Overcoming Past Obstacles With Advances in Understanding.

Niacin action in the atherogenic mixed dyslipidemia of metabolic syndrome: Insights from metabolic biomarker profiling and network analysis Martin Adiels,

Volume 153, Issue 3, Pages e7 (September 2017)

A Blend of Sesame and Rice Bran Oils Lowers Hyperglycemia and Improves the Lipids Sankar Devarajan, PhD, Biprabuddha Chatterjee, MSc, Hidenori Urata,

Endocrine and cardiometabolic cord blood characteristics of offspring born to mothers with and without polycystic ovary syndrome Nadine M.P. Daan, M.D.,

Volume 15, Issue 4, Pages (July 2015)

Volume 153, Issue 3, Pages e7 (September 2017)

Metabolic Syndrome (N=160) Non-Metabolic Syndrome (N=138) 107/53

Fructose as a Driver of Diabetes: An Incomplete View of the Evidence

Effects of highly concentrated SFN provided as BSE in T2D patients

Fellström BC, et al. N Engl J Med 2009;360:1455-7

Figure 3 Clinical algorithms in the management of NASH and diabetes mellitus Figure 3 | Clinical algorithms in the management of NASH and diabetes mellitus.

THE RELATIONSHIP BETWEEN OBESITY, INFLAMMATION MARKERS,

OR (95% CI) for CHD associated with inflammatory markers before and after adjustment for established risk factors. OR (95% CI) for CHD associated with.

A B D C Total adiponectin (μg/ml ) Hb ( g / dl ) r = p = 0.003

Subject Characteristics

Trajectories of cardiometabolic risk factors before diagnosis of three subtypes of type 2 diabetes: a post-hoc analysis of the longitudinal Whitehall.

HOMA calculations where glucose is mmol/L and insulin is mU/L

Heart Protection Study Collaborative Group Lancet 2011;377:469-76

Flow of Patients Through Trial

Switch to RAL-containing regimen

Baseline Characteristics of the Subjects*

Elevated High-Density Lipoprotein Cholesterol Is Associated with Hyponatremia in Hypertensive Patients Ariel Israel, MD, PhD, Ehud Grossman, MD The.

Disposition of Patients in the Atherogenic Dyslipidemia Study

(A) Low-density lipoprotein-cholesterol (LDL-C) values at baseline and after treatment with anagliptin in 20 participants at 12 and 24 weeks. (A) Low-density.

PROSPER: trial design

Intensive Lowering of Low-Density Lipoprotein Cholesterol Levels for Primary Prevention of Coronary Artery Disease Dean G. Karalis, MD Mayo Clinic Proceedings

The ACCORD Study Group. NEJM 2010; Epub March 14

Monitoring for diabetic complications in home care baseline data

Change in markers of glycometabolism and cardiovascular risk profile.

Total T2D risk according to join distribution of GGT and ALT

Improved monitoring of diabetic parameters outcome data

Individual lipid measures for high-carbohydrate (n=10) and low-carbohydrate (n=10) ultra-endurance athletes. Individual lipid measures for high-carbohydrate.

Baseline characteristics of the participants according to study group.

Volume 74, Pages S4-S9 (December 2008)

© The Author(s) Published by Science and Education Publishing.

© The Author(s) Published by Science and Education Publishing.

Effects of highly concentrated SFN provided as BSE in T2D patients

Differences in changes in total cholesterol, LDL-cholesterol, HDL-cholesterol and triglycerides (expressed as mg/dL) between patients with hyperlipidaemia.

Changes of major clinical and biochemical characteristics at baseline and during follow-up in different groups. Changes of major clinical and biochemical.

Presentation transcript:

Time frame : Baseline to post intervention Additional file 2: Outcome measures Domain Glycaemic control Lipid profile Inflammation Specific Measurement HbA1c Fasting glucose Insulin HOMA-IR Total cholesterol Triglycerides HDL-C, LDL-C Total:HDL-C CRP FBC IL-6, IL-1β Adiponectin, Leptin HbA1c Time frame : Baseline to post intervention ( 12 Weeks) Specific Metric Change from baseline Method of Aggregation Continuous Mean or Median Abbreviations: HbA1c-Glycosylated Haemoglobin; HOMA-IR-Homeostatic model assessment for insulin resistance; HDL-C- High density lipoprotein cholesterol; LDL-C-Low density lipoprotein cholesterol; CRP- C reactive protein; FBC-full blood cell count; IL-6&IL-1β- Interleukin 6 and interleukin 1β. Blue coloured boxes represent primary outcome measure in this trial.